Who has invested in Theravectys?

Boehringer Ingelheim Venture Fund (BIVF), Kurma Partners, Idinvest, Gimv, LSP are named among the investors backing Theravectys.

Theravectys Funding: $22M Raised, Series A (2017)

Theravectys funding overview

Theravectys is based in Paris, France. Theravectys has raised $22M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in May 2017. The round record for Theravectys runs through 2017; nothing later has been disclosed. Investors on record include Boehringer Ingelheim Venture Fund (BIVF), Kurma Partners, Idinvest, Gimv, LSP. 5 distinct backers are named across the disclosed rounds.

Theravectys at a glance

Total raised: $22M
Latest round: Series A
Latest round date: May 2017
Headquarters: Paris, France
Notable investors: Boehringer Ingelheim Venture Fund (BIVF), Kurma Partners, Idinvest, Gimv, LSP

Frequently asked about Theravectys funding

How much has Theravectys raised?: Theravectys has raised $22M in total disclosed funding across the rounds on record.
Who has invested in Theravectys?: Boehringer Ingelheim Venture Fund (BIVF), Kurma Partners, Idinvest, Gimv, LSP are named among the investors backing Theravectys.
What was the latest Theravectys funding round?: The most recent disclosed round is a Series A, announced in May 2017.
Where is Theravectys based?: Theravectys is based in Paris, France.
When did Theravectys last raise?: The last disclosed Theravectys round closed in May 2017 at Series A.

Every Theravectys figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Paris at a similar stage.

Theravectys Funding: $22M Raised, Series A (2017)

Theravectys funding overview

Theravectys at a glance

Frequently asked about Theravectys funding

Companies related to Theravectys (18)

Browse related funding lists (8)